Azitra (AZTR) Amortizatization of Intangibles (2022 - 2026)
Azitra (AZTR) reported Amortizatization of Intangibles of $78961.0 for Q1 2026, down 5.28% on a YoY basis from $83360.0 in Q1 2025, and up 1.11% quarter-over-quarter from $78094.0 in Q4 2025.
Azitra (AZTR) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Azitra has reported Amortizatization of Intangibles for 5 years, with the latest figure at $78961.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 5.28% year-over-year to $78961.0; the trailing twelve-month figure through Mar 2026 stood at $310676.0 (down 2.28% YoY), and the FY2025 full-year result was $315075.0, down 0.62% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $78961.0, up from $78094.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $274197.0 in Q4 2022, with the low at -$135026.0 in Q3 2022.
- Historically, Amortizatization of Intangibles has averaged $76410.0 across 5 years, with a median of $78094.0 in 2025.
- The largest YoY upside for Amortizatization of Intangibles was 159.19% in 2023 against a maximum downside of 72.2% in 2023.
- Azitra's Amortizatization of Intangibles stood at $274197.0 in 2022, then sank by 72.2% to $76238.0 in 2023, then rose by 8.23% to $82510.0 in 2024, then decreased by 5.35% to $78094.0 in 2025, then grew by 1.11% to $78961.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $78961.0 (Q1 2026), $78094.0 (Q4 2025), and $77235.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | 78,961.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78,961.00 |
| Mar 31, 2026 | 78,961.00 |
| Dec 31, 2025 | 78,094.00 |
| Dec 31, 2025 | 78,094.00 |
| Sep 30, 2025 | 77,235.00 |
| Sep 30, 2025 | 77,235.00 |
| Jun 30, 2025 | 76,386.00 |
| Jun 30, 2025 | 76,386.00 |
| Mar 31, 2025 | 83,360.00 |
| Mar 31, 2025 | 83,360.00 |
| Dec 31, 2024 | 82,510.00 |
| Dec 31, 2024 | 82,510.00 |
| Sep 30, 2024 | 70,636.00 |
| Sep 30, 2024 | 70,636.00 |
| Jun 30, 2024 | 81,434.00 |
| Jun 30, 2024 | 81,434.00 |
| Mar 31, 2024 | 82,467.00 |
| Mar 31, 2024 | 82,467.00 |
| Dec 31, 2023 | 76,238.00 |
| Dec 31, 2023 | 76,238.00 |